ArticleCancers2023

The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Real-World Cohort Study.

Koji Iinuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.